STOCK TITAN

ClearOne raises $2.76M, converts $1.24M in debt

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

ClearOne, Inc. (CLRO) completed a private placement and converted First Finance debt into shares on November 17, 2026. It issued 311,114 shares to First Finance to settle $1,244,458 of debt, and sold 688,885 shares at $4.00 each for $2,755,540 in gross cash proceeds. In total, ClearOne issued 999,999 shares for $3,999,998 in consideration; 3,675,411 shares were outstanding after closing. The company intends to use net placement proceeds for working capital and general corporate purposes.

Nasdaq staff had determined ClearOne did not meet its $2,500,000 minimum stockholders’ equity requirement and decided to delist its securities. ClearOne appealed, staying the suspension pending a Panel decision; a hearing was scheduled for November 17, 2026. Preliminary, unaudited pro forma stockholders’ equity was $3,282,000, above the minimum, but Nasdaq has not confirmed compliance and there is no assurance the Panel will grant continued listing. Final amounts may differ materially, and the next periodic report is ClearOne’s 2026 Form 10-K.

1 point · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

1 major · 1 point

Hollow bars mark forward-looking points. How the balance works

Positive

  • Moderate pointPreliminary pro forma equity of $3.282 million exceeds Nasdaq’s $2.5 million minimum.

Negative

  • Major point. Forward-looking: it has not happened yet and may not happen.Nasdaq delisting remains possible pending the November 17, 2026 Panel hearing.

Filing Explained

Before the financing closed, September thirtieth cash was equivalent to one point one days of the last reported quarterly operating cash use.

The debt conversion and private placement are complete; the pro forma balance sheet treats them as if they occurred on September 30, 2026, but excludes the pending Cortigent merger, related S-1 public offering, and shares under advisor agreements, so its equity figure does not include those items.

That pro forma reports equity and includes a noncash release of unrecognized tax benefits after the statute of limitations expired on October 15, 2026.

Sources and calculations
  • Available liquidity against the last reported quarterly operating outflow, in days at that rate $18,000 / ($1,558,000 / 92) = 1.1 days
Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 3.02 Unregistered Sales of Equity Securities Securities
The company sold equity securities in a private placement or other unregistered transaction.
Item 7.01 Regulation FD Disclosure Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Private placement shares 688,885 shares Sold at $4.00 per share
Purchase price $4.00 per share Private placement
Gross cash proceeds $2,755,540 Private placement
Total shares issued 999,999 shares Debt conversion and private placement
Aggregate consideration $3,999,998 Debt conversion and private placement
Shares outstanding 3,675,411 shares Following closing
Pro forma stockholders’ equity $3,282,000 Preliminary, unaudited pro forma balance sheet
Nasdaq minimum stockholders’ equity requirement $2,500,000 Continued listing requirement
Debt Conversion financial
"311,114 shares of Common Stock issued in full and final satisfaction"
Stockholders’ Equity Requirement regulatory
"the $2,500,000 minimum stockholders’ equity requirement"
A stockholders’ equity requirement is a minimum amount of net assets — assets minus liabilities — that a company must keep on its balance sheet to meet rules set by regulators, lenders or stock exchanges. Think of it as a required safety buffer or minimum bank balance that shows the company has enough of its own capital to absorb losses; falling below it can limit dividends, trigger covenants or risk sanctions, so investors watch it as a sign of financial health and compliance.
pro forma condensed consolidated balance sheet financial
"unaudited pro forma condensed consolidated balance sheet"
Rule 506(b) regulatory
"Rule 506(b) of Regulation D"
Rule 506(b) is a U.S. securities exemption that lets companies sell shares or debt privately without full public registration, provided sales are primarily to accredited investors, up to 35 non‑accredited but financially knowledgeable buyers, and there is no public advertising or solicitation. It matters to investors because offerings under 506(b) usually include less public disclosure than registered securities—like buying from a private seller rather than a retail store—so buyers must do more of their own fact‑checking and rely on their financial sophistication.
unrecognized tax benefits financial
"liability for unrecognized tax benefits of $392"
additional paid-in capital financial
"recorded in additional paid-in capital"
Amount of money shareholders have paid to a company for shares that is above the stock’s nominal or par value; think of it as the extra premium paid when a group buys a ticket that has a low listed price. It matters to investors because it represents permanent capital on the balance sheet that can cushion losses, affect book value per share and indicate how much fresh cash equity holders have contributed beyond the minimum share value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much cash did CLRO raise in its private placement?

ClearOne reported $2,755,540 in aggregate gross cash proceeds from the private placement. First Finance paid $755,540 for 188,885 shares, and other accredited investors purchased 500,000 shares for $2,000,000. Separately, First Finance received 311,114 shares in settlement of $1,244,458 of indebtedness.

How many shares did CLRO issue, and how many were outstanding after closing?

ClearOne issued 999,999 shares in the debt conversion and private placement for $3,999,998 in aggregate consideration. Following closing, the company had 3,675,411 shares outstanding.

Will CLRO remain listed on Nasdaq?

Continued Nasdaq listing was not assured: ClearOne’s appeal stayed the suspension pending the Panel’s decision, and a hearing was scheduled for November 17, 2026. Preliminary unaudited pro forma equity was $3,282,000, above the $2,500,000 minimum, but Nasdaq had not confirmed compliance and delisting remained possible.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0000840715 CLEARONE INC 00008407152026-11-132026-11-13

 

 

 

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): November 13, 2026

 

ClearOne, Inc.

(Exact name of registrant as specified in its charter)

 

Nevada

 

001-33660

 

87-0398877

(State or Other Jurisdiction of Incorporation)

 

(Commission File Number)

 

(I.R.S. Employer Identification No.)

 

7533 S Center View Ct. # 5311, West Jordan, Utah

 

84084

(Address of principal executive offices)

 

(Zip Code)

 

+1 (801) 975-7200

(Registrant’s telephone number, including area code)

 

Not applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).


Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Securities Registered Pursuant to Section 12(b) of the Act:  

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $0.001

CLRO

The NASDAQ Capital Market

 




Item 1.01             Entry into a Material Definitive Agreement.


On November 13, 2026, ClearOne, Inc. (the “Company”) entered into private placement subscription agreements (each, a “Subscription Agreement”) with certain investors, pursuant to which the investors subscribed for an aggregate of 688,885 shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”) at a purchase price of $4.00 per share, for aggregate gross proceeds of $2,755,540. The Subscription Agreements contain customary representations, warranties and acknowledgements of the investors. The Subscription Agreements are substantially identical in all material respects other than the identity of the investor and the number of shares purchased.


The information set forth in Item 3.02 of this Current Report on Form 8-K regarding the Debt Settlement Agreement (as defined below), the Debt Conversion (as defined below) and the Private Placement (as defined below) is incorporated by reference into this Item 1.01.


Item 3.02              Unregistered Sales of Equity Securities.


On November 13, 2026, the Company entered into a Debt Settlement Agreement (the “Debt Settlement Agreement”) and a Subscription Agreement with First Finance, pursuant to which the Company agreed to issue an aggregate of 499,999 shares of Common Stock to First Finance at a deemed price of $4.00 per share, consisting of (i) 311,114 shares of Common Stock issued in full and final satisfaction of the aggregate amount of $1,244,458 of indebtedness owed by the Company to First Finance, consisting of $1,200,000 in principal and $44,458 in accrued interest (the “Debt Conversion”), and (ii) 188,885 shares of Common Stock purchased by First Finance for $755,540 in cash (the “Cash Purchase”). The Debt Conversion closed on November 17, 2026 upon the issuance of Common Stock to First Finance.


On November 17, 2026, the Company also completed a private placement of an aggregate of 500,000 shares of Common Stock to other accredited investors at a purchase price of $4.00 per share for aggregate gross proceeds of $2,000,000 (together with the Cash Purchase, the “Private Placement”). In total, the Company issued 999,999 shares of Common Stock in the Debt Conversion and the Private Placement for aggregate consideration of $3,999,998, including aggregate cash proceeds of $2,755,540. Following the closing, the Company had 3,675,411 shares of Common Stock outstanding. The Company intends to use the net proceeds from the Private Placement for working capital and general corporate purposes.


The Common Stock issued in the Debt Conversion and the Private Placement have not been registered under the Securities Act, and were offered and sold in reliance upon the exemption from registration provided by Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D promulgated thereunder, as well as Regulation S for offshore investors.


The foregoing descriptions of the Debt Settlement Agreement and the Subscription Agreements do not purport to be complete and are qualified in their entirety by reference to the full text of the Debt Settlement Agreement and the form of Subscription Agreement, which are filed as Exhibits 10.1 and 10.2, respectively, to this Current Report on Form 8-K and incorporated herein by reference.


Item 7.01              Regulation FD Disclosure.


As previously disclosed, on April 7, 2026, the Company received a notice from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the Company no longer complied with the continued listing requirements set forth in Nasdaq Listing Rule 5550(b). On October 8, 2026, the Company received a Staff determination letter notifying the Company that it had not demonstrated compliance with the $2,500,000 minimum stockholders’ equity requirement for continued listing set forth under Nasdaq Listing Rule 5550(b)(1) (the “Stockholders’ Equity Requirement”) because the Company had not completed the remedial actions contemplated by the compliance plan submitted to Nasdaq on May 22, 2026. Accordingly, the Staff determined to delist the Company’s securities from The Nasdaq Capital Market. On October 14, 2026, the Company requested a hearing before a Nasdaq Hearings Panel (the “Panel”) which stayed the suspension of the Common Stock pending the Panel’s decision, and paid a non-refundable appeal fee of $20,000. The hearing before the Panel is scheduled for November 17, 2026. There can be no assurance that the Panel will grant the Company’s request for continued listing or that the Company will regain compliance with the Nasdaq’s continued listing requirements. If the Panel does not grant the Company’s request, the Common Stock would be delisted from Nasdaq.

The Company is providing the unaudited pro forma condensed consolidated balance sheet as of September 30, 2026 and the accompanying notes furnished as Exhibit 99.1 to this Current Report on Form 8-K (the “Pro Forma Information”). The Pro Forma Information gives effect to the Debt Conversion and the Private Placement as if they had occurred on September 30, 2026. It reflects pro forma stockholders’ equity of $3,282,000, exceeding the Stockholders’ Equity Requirement.





Nasdaq will continue to monitor the Company’s ongoing compliance with the Stockholders’ Equity Requirement and, if at the time of its next periodic report the Company does not evidence compliance, the Company may be subject to delisting. The Company’s next periodic report will be its Annual Report on Form 10-K for the year ending December 31, 2026. The Company intends to submit this Current Report on Form 8-K to the Panel in support of a determination that the Company has regained compliance with the Stockholders’ Equity Requirement. This Current Report on Form 8-K and the Pro Forma Information are being provided in connection with the Company’s request for a favorable Panel determination. They do not constitute Nasdaq confirmation that the deficiency has been resolved or that the delisting proceedings have been terminated.

Based on the Debt Conversion, Private Placement and management’s assessment of the Company’s financial condition, the Company believes that it has regained compliance with the Stockholders’ Equity Requirement. The Company has requested that the Panel resolve the previously disclosed stockholders’ equity deficiency and confirm the Company’s compliance. There can be no assurance that the Panel or Nasdaq will determine that the Company has regained compliance, that any such determination will not be subject to conditions or a monitoring period, or that the Company will be able to maintain compliance with the Stockholders’ Equity Requirement or Nasdaq’s other continued listing requirements.

The Pro Forma Information was prepared by the Company’s financial personnel and is the responsibility of management. It is preliminary, unaudited and based on information available as of November 17, 2026. The presentation does not include all financial statements and disclosures required by generally accepted accounting principles in the United States (“U.S. GAAP”) and should not be viewed as a substitute for the Company’s financial statements prepared in accordance with U.S. GAAP. It should be read together with the Company’s previously filed financial statements and related notes.

The information remains subject to the completion of financial statement preparation, account reconciliations, closing procedures and the finalization of estimates and accounting analyses, as well as adjustments arising from the independent registered public accounting firm’s review of the Company’s quarterly financial statements and audit of its annual financial statements. Potential adjustments include the allocation of financing proceeds and offering costs; accrued liabilities; compensation expense; and other financial statement items. Final reported amounts may differ materially from the preliminary amounts presented, and any difference could affect the Company’s assessment of compliance with the Stockholders’ Equity Requirement.


The Pro Forma Information reflects only the specified transactions and assumptions described in Exhibit 99.1. It is not a representation of the Company’s actual financial position on November 17, 2026, a projection of results for the year ending December 31, 2026, or an assurance of continued listing. Further operating losses, dividends, expenses or other charges may reduce stockholders’ equity. Investors are cautioned against placing undue reliance on this preliminary information.


The information in this Item 7.01, including Exhibit 99.1, is furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section. It shall not be incorporated by reference into any filing under the Securities Act or the Exchange Act, except to the extent expressly incorporated by specific reference in that filing. This report does not constitute an offer to sell or a solicitation of an offer to buy any securities. The Private Placement securities have not been registered under the Securities Act and may be offered or sold only pursuant to registration or an applicable exemption.





Forward-Looking Statements


This Current Report on Form 8-K contains forward-looking statements. To the extent applicable, the Company intends these statements to be covered by the safe harbor provisions of Section 27A of the Securities Act, and Section 21E of the Exchange Act. Forward-looking statements include expectations regarding final financial reporting and accounting treatment; the timing and outcome of Nasdaq’s and the Panel’s review; the Company’s ability to regain and maintain compliance with Nasdaq’s continued listing requirements; and future stockholders’ equity, financial condition and capital needs. Words such as “believes,” “expects,” “estimates,” “anticipates,” “intends” and “may” and similar expressions may identify such statements.

These statements are based on current expectations and assumptions and involve risks and uncertainties that may cause actual outcomes to differ materially. Those risks include adjustments identified during closing, review and audit procedures; differences between estimated and actual offering costs; additional operating losses; Nasdaq’s exercise of discretion in evaluating both current equity and the ability to sustain compliance; additional conditions or information required by Nasdaq; an adverse Panel determination; the Company’s ability to satisfy other listing standards, obtain required stockholder approvals and comply with its financing and registration rights obligations; and the availability of additional capital if needed. Additional risks are described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, and its subsequent reports and other filings with the Securities and Exchange Commission.


Forward-looking statements are not guarantees of future performance or of a favorable Nasdaq determination and speak only as of the date made. Except as required by applicable law, the Company undertakes no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise.


Item 9.01             Financial Statements and Exhibits


(d)  Exhibits 

Exhibit Number

 

Exhibit Title

10.1
Debt Settlement and Subscription Agreement, dated November 13, 2026 by and between ClearOne, Inc. and First Finance Ltd.
10.2
Form of Subscription Agreement, dated November 13, 2026, by and between ClearOne, Inc. and each of the investors party thereto.
99.1
Unaudited Pro Forma Condensed Consolidated Balance Sheet as of September 30, 2026 and accompanying notes.

104

 

The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.

 




SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

CLEARONE, INC.

 

 

 

Date:  November 17, 2026

By:

/s/ Simon Brewer

 

 

Simon Brewer

 

 

Chief Financial Officer


Exhibit 99.1


CLEARONE, INC.

UNAUDITED PRO FORMA CONDENSED CONSOLIDATED BALANCE SHEET

AS OF SEPTEMBER 30, 2026

(Dollars in thousands, except share amounts)

 

Historical (Form 10-Q)

(a) First Finance October advance

(b) Debt conversion

(c) Private placement

(d) FIN 48 release

Pro Forma

ASSETS

 

 

 

 

 

 

Current assets:







Cash and cash equivalents

$ 18

$ 200

—

$ 2,756

—

$ 2,974

Restricted cash

50

—

—

—

—

50

Inventories, net

278

—

—

—

—

278

Prepaid assets

135

—

—

—

—

135

Current assets related to discontinued operations

129

—

—

—

—

129

Total current assets

610

200

—

2,756

—

3,566

Long-term assets related to discontinued operations

13

—

—

—

—

13

Total assets

$ 623

$ 200

—

$ 2,756

—

$ 3,579

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIT)

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Accounts payable

$ 99

—

—

—

—

$ 99

Accrued liabilities

56

—

—

—

—

56

Short-term note payable — related party

1,025

200

(1,225)

—

—

—

Current liabilities related to discontinued operations

93

—

—

—

—

93

Total current liabilities

1,273

200

(1,225)

—

—

248

Long-term liabilities related to discontinued operations

441

—

—

—

(392)

49

Total liabilities

1,714

200

(1,225)

—

(392)

297

 

 

 

 

 

 

 

Shareholders' equity (deficit):

 

 

 

 

 

 

Common stock, par value $0.001

3

—

—

1

—

4

Additional paid-in capital

37,500

—

1,225

2,755

—

41,480

Accumulated other comprehensive loss

(341)

—

—

—

—

(341)

Accumulated deficit

(38,253)

—

—

—

392

(37,861)

Total shareholders' equity (deficit)

(1,091)

—

1,225

2,756

392

3,282

Total liabilities and shareholders' equity (deficit)

$ 623

$ 200

—

$ 2,756

—

$ 3,579

 

 

 

 

 

 

 

Common shares outstanding

2,675,412

—

311,114

688,885

—

3,675,411

See accompanying notes to the unaudited pro forma condensed consolidated balance sheet.

1


NOTES TO THE UNAUDITED PRO FORMA CONDENSED CONSOLIDATED BALANCE SHEET

1. Basis of Presentation

The unaudited pro forma condensed consolidated balance sheet is derived from the unaudited condensed consolidated balance sheet of ClearOne, Inc. (the “Company”) as of September 30, 2026, included in the Company’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 10, 2026. It gives effect to the transactions and the event described in Note 2 as if they had occurred on September 30, 2026. It has been prepared by management, is unaudited and does not include all disclosures required by accounting principles generally accepted in the United States. It is presented to illustrate the Company’s stockholders’ equity for purposes of Nasdaq Listing Rule 5550(b)(1) and is not necessarily indicative of the Company’s financial position as of any future date.

2. Pro Forma Adjustments

(a) First Finance October advance. Reflects the $200 unsecured, non-interest-bearing advance received from First Finance Ltd. (“First Finance”), a related party, on October 7, 2026 under a loan agreement dated October 7, 2026, as an increase to cash and to the note payable to First Finance.

(b) Debt conversion. Reflects the Debt Settlement and Subscription Agreement with First Finance, under which the Company issued 311,114 shares of common stock at a deemed price of $4.00 per share, rounded down to whole fully paid shares, in full satisfaction of $1,244,458.33 of indebtedness, consisting of $1,200,000 of principal (including the advance in (a)) and $44,458.33 of interest accrued to November 17, 2026. Together with its cash subscription in (c), First Finance will receive 499,999 shares. The adjustment removes the carrying amount of the indebtedness at September 30, 2026 ($1,025, consisting of principal of $1,000 and accrued interest of $25, plus the $200 advance in (a)). Because First Finance is a related party, the difference between the fair value of the shares issued and the carrying amount of the indebtedness extinguished is recorded in additional paid-in capital, and no gain or loss is recognized. Interest accruing after September 30, 2026 is expensed as incurred and extinguished on settlement, with no net effect on stockholders’ equity.

(c) Private placement. Reflects the sale of 688,885 shares of common stock at $4.00 per share in a private placement for gross cash proceeds of $2,756 ($2,755,540), consisting of 188,885 shares purchased by First Finance for $755,540 and 500,000 shares purchased by other investors for $2,000,000. No placement fees or other offering costs are payable.

(d) Release of unrecognized tax benefits. The statute of limitations for the Company’s 2022 federal and state income tax returns expired on October 15, 2026. On October 16, 2026, the Company derecognized the related liability for unrecognized tax benefits of $392, which was included in long-term liabilities related to discontinued operations, with a corresponding income tax benefit in discontinued operations. The release is non-cash.

3. Items Not Reflected

The unaudited pro forma condensed consolidated balance sheet does not reflect (i) the Company’s results of operations after September 30, 2026, other than the release described in (d); (ii) the pending merger with Cortigent, Inc. and the related public offering under the Company’s registration statement on Form S-1; or (iii) the issuance of shares under advisor agreements dated August 7, 2026.

2


Filing Exhibits & Attachments

8 documents

Keep reading